Webinars & Podcasts

Serum Osmolality Disorders — Importance, Evaluation and Treatment

Hyponatremia is a common condition in both hospitalized patients and in the community. It is associated with multiple adverse outcomes including an increased risk of falls and fractures which can be particularly devastating for elderly patients. In addition, hyponatremia in hospitalized patients has been associated with prolonged hospital stays and higher in-hospital mortality. Thus, the ability to accurately diagnose the cause of hyponatremia as well as determine the proper course of treatment is vital. Measurement of the serum and urine osmolality plays a key role in the management of patients with hyponatremia. The serum sodium level is a surrogate marker of the serum osmolality but has important limitations and cannot take the place of osmolality testing in making an initial diagnosis. Serial measurements of the urine osmolality and electrolytes is necessary to guide the treatment of hyponatremia as the character of the urine can change in response to fluid and diuretic administration.

In this webinar, the featured speakers will discuss the epidemiology of hyponatremia as well as the common causes. They will discuss how to diagnose the cause of hyponatremia highlighting the key role that urine and serum osmolality testing plays in the management of these patients. The speakers will also introduce a novel topic including the basic urine metabolic panel (an order set that includes both urine electrolytes and osmolality to aid in seamless ordering of these tests) to prevent overcorrection in patients with chronic hyponatremia. Overly rapid correction of hyponatremia is known to cause osmotic demyelination — an iatrogenic brain injury that can lead to permanent disability. The speakers will, in addition, discuss the technology used to measure serum and urine osmolality.

Register for this webinar to develop a comprehensive understanding of the importance of hyponatremia, the key causes and the specific roles that laboratory tests including urine and serum osmolality play in guiding clinical care for this common and difficult to manage condition.

Related Resources

Learn more by checking out our additional educational resources below.

Clinical Case Study

Keeping Plasma Safe: Haematologic Technologies Inc. Implements the Artel PCS for Quality Assurance

View

Clinical Case Study

Improving cell count turnaround times with the GloCyte Automated Cell Counter

View

Clinical Case Study

The Impact of the Artel MVS: When Analyzing Cancer at the Molecular Level, Microliters Matter

View

Clinical App Note

Reducing Error Associated with Manual Chamber Counts with the GloCyte® Automated Cell Counter for CSF

View

Clinical App Note

Clinical Osmometer Applications

View

Clinical App Note

The Importance of Measured Osmolality Testing With an In-house Osmometer

View

Clinical Webinar

Virtual Demo | GloCyte® Automated Cell Counter for CSF

View

Clinical Webinar

Virtual Demo | Artel PCS® Pipette Calibration System

View

Clinical Webinar

Virtual Demo | Anoxomat® III Anaerobic Jar System

View

Clinical Posters

Reducing Cell Count Bias with the GloCyte® Automated Cell Counter for CSF

View

Clinical Posters

Improving cell count turnaround times with the GloCyte® Automated Cell Counter for CSF

View

Clinical Posters

Shining Renewed Light on a Tried-and-True Test: The Critical Role of Osmolality Testing in Improving Health and Economic Outcomes in Patients with Hyponatremia

View

Clinical Knowledge Center

The Value of Our Clinical Osmometers

View

Clinical Knowledge Center

Measuring the Impact of Common Environmental Conditions on Laboratory Data Integrity

View

Clinical Knowledge Center

Freezing Point Depression Theory

View